RBI and IRDAI Resist Entry of Banks and Insurers into Commodity Derivatives Market: SEBI Chair

India's Commodity Derivatives Push Hits Pause as Regulators Opt to Stay On Sidelines

India's efforts to broaden participation in commodity derivatives markets have stalled, with key financial regulators, including the Reserve Bank of India (RBI) and the Insurance Regulatory and Development Authority of India (IRDAI), exercising caution and opting to stay on the sidelines for now.

Speaking at the IMC Capital Markets Conference, Tuhin Kanta Pandey, chairman of the Securities and Exchange Board of India (SEBI), revealed that the RBI and IRDAI have expressed reservations about allowing banks and insurance companies to participate in commodity derivatives trading. This decision marks a pause in SEBI's earlier plans to engage with policymakers to explore widening the investor base in commodities, including permitting banks and pension funds to enter the segment.

SEBI had initially indicated that it would work with policymakers to explore the possibility of allowing banks and pension funds to invest in commodities. However, this proposal has not received regulatory support, with the RBI and IRDAI citing concerns about the suitability of such instruments for certain financial institutions.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

A key concern is the alignment of commodity derivatives with the core investment strategies of insurers. Pandey pointed out that commodity derivatives may not be suitable for insurance firms, which typically focus on long-term investments. He noted that commodity derivatives "don't make much sense for insurance firms."

The pension sector regulator has also examined the possibility of allowing pension funds to invest in commodities, although no decision has been reached. For now, SEBI is unlikely to push the proposal further, with Pandey suggesting that any expansion of participation in commodity derivatives will have to wait until broader regulatory consensus emerges.